Abstract
AbstractLong-term immunity after HBV vaccination is still debated. When assessing immune persistence, several variables must be considered, the clear definition of which is crucial. Our aim was to assess protection 10–20 years after primary vaccination and to estimate the effect of age at first dose, sex and time elapsed between doses on long-term protection. We conducted a retrospective cohort study between January 2004 and December 2020. Antibody titres above 10 IU/L were considered protective. Geometric mean titres (GMT) were calculated. The effect of the above variables on long-term protection was assessed by logistic regression analysis. Included participants were 9459. Among those vaccinated during infancy, GMT gradually increased from 11 IU/L (first dose in 1st trimester of life) to 68 IU/L (4th trimester), while the proportion of individuals <10 IU/L remained stable between 1st and 2nd trimester (51%) and it decreased substantially in 3rd (28%) and even more so in the 4th (18%). A one-month delay in first and third dose administration was correlated with a −16% (AOR: 0.84; 95% CI: 0.78–0.91) and a −11% (AOR: 0.89; 95% CI: 0.85–0.94) risk of a titre <10 IU/L, respectively, ~20 years after immunisation. In contrast, similar changes do not comparably affect vaccination in adolescence. The start of vaccination at the third month of age is a compromise between the development of acceptable immunogenicity and the need to protect the infant as early as possible. However, the chance of slightly delaying the vaccine administration within the first year of life may be considered given the impact on long-term persistence of anti-HBs.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Reference47 articles.
1. WHO. Hepatitis B, Fact sheets n.d. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (2022).
2. Stefanati, A. et al. Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors. J. Prev. Med. Hyg. 60, E184–E190 (2019).
3. Istituto Superiore di Sanità. Sistema epidemiologico integrato delle epatiti virali acute - SEIEVA n.d. https://www.epicentro.iss.it/epatite/dati-seieva (2022).
4. Osiowy, C. From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity. Hum. Vaccin Immunother. 14, 2093–2097 (2018).
5. Siegrist, C.-A. & Aspinall, R. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 9, 185–194 (2009).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献